Works matching IS 01986325 AND DT 2018 AND VI 38 AND IP 5


Results: 11
    1
    2
    3

    Biologically active quinoline and quinazoline alkaloids part II.

    Published in:
    Medicinal Research Reviews, 2018, v. 38, n. 5, p. 1614, doi. 10.1002/med.21492
    By:
    • Shang, Xiao‐Fei;
    • Morris‐Natschke, Susan L.;
    • Yang, Guan‐Zhou;
    • Liu, Ying‐Qian;
    • Guo, Xiao;
    • Xu, Xiao‐Shan;
    • Goto, Masuo;
    • Li, Jun‐Cai;
    • Zhang, Ji‐Yu;
    • Lee, Kuo‐Hsiung
    Publication type:
    Article
    4

    Heparin mimetics with anticoagulant activity.

    Published in:
    Medicinal Research Reviews, 2018, v. 38, n. 5, p. 1582, doi. 10.1002/med.21489
    By:
    • Nahain, Abdullah Al;
    • Ignjatovic, Vera;
    • Monagle, Paul;
    • Tsanaktsidis, John;
    • Ferro, Vito
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Potential cardiac risk of immune‐checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects.

    Published in:
    Medicinal Research Reviews, 2018, v. 38, n. 5, p. 1447, doi. 10.1002/med.21478
    By:
    • Spallarossa, Paolo;
    • Meliota, Giovanni;
    • Brunelli, Claudio;
    • Arboscello, Eleonora;
    • Ameri, Pietro;
    • Dessalvi, Christian Cadeddu;
    • Grossi, Francesco;
    • Deidda, Martino;
    • Mele, Donato;
    • Sarocchi, Matteo;
    • Bellodi, Andrea;
    • Madonna, Rosalinda;
    • Mercuro, Giuseppe
    Publication type:
    Article
    11

    Issue Information ‐ TOC.

    Published in:
    Medicinal Research Reviews, 2018, v. 38, n. 5, p. 1443, doi. 10.1002/med.21471
    Publication type:
    Article